Shengjian Zhang

机构：Fudan University Shanghai Cancer Center · ORCID：0000-0002-0225-8828

发表论文 71 篇 · 总被引 3712 次 · h-index 24

代表论文

• Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma (2022 · BMC Cancer · 被引 41)
• Redox chemistry-enabled stepwise surface dual nanoparticle engineering of 2D MXenes for tumor-sensitive T 1 and T 2 MRI-guided photonic breast-cancer hyperthermia in the NIR-II biowindow (2022 · Biomaterials Science · 被引 34)
• Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trial (2024 · EClinicalMedicine · 被引 32)
• Novel Assumption about the Mechanism of Catalytic Gasification: On the Basis of the Same Catalytic Effect of Alkali between C–CO 2 and Fe–CO 2 Reactions (2021 · Energy & Fuels · 被引 15)
• Anlotinib versus Placebo as Adjuvant Therapy for Localized High-Grade Soft-Tissue Sarcomas: A Phase II, Double-Blinded, Randomized Controlled Trial (2025 · Clinical Cancer Research · 被引 9)
• Ultrasound-enhanced cascade chemodynamic tumor nanotherapy with lactic acid-enabled hydrogen peroxide self-production (2022 · Biomaterials Science · 被引 9)